The crystal structure of neurotoxin a from the venom of Philippines sea snake Laticauda semifasciata has been determined at 2.5 A resolution by x-ray diffraction. Comparison with the structure of neurotoxin b from the same source indicates that the two toxins differ only by substitution at His 26. Earlier chemical work had suggested a difference in chain length and considerable differences in amino acid composition. The difference between our a and b toxins is the same as that reported from sequence analysis for the related erabutoxins a and b from Japanese sea snake, and suggests that the Philippines toxin may be identical to erabutoxin. The replacement of His 26 by a shorter side-chain in toxin a has no effect on the structure of the rest of the molecule. In particular, the protruding loop, which we believe interacts with the acetylcholine receptor, is not affected, even though His 26 is in the loop. Postsynaptic a-neurotoxins from snake venom have recently become the object of intense chemical and biological study because of their specific, tight binding to the nicotinic acetylcholine receptor of the muscle motor end plate. We have reported (1) the crystal structure of a-neurotoxin b from the venom of the sea snake Laticauda semifasciata from the Philippines Sea (Fig. 1 )*. Here we report the structure of a'-neurotoxin a from the same source and the implication of our work for the biological action of the toxins as well as for earlier chemical work (3, 4) .
Abbreviations: erabutoxins a and b, principal neurotoxic components of the venom of Japanese sea snake; toxins a and b, the neurotoxic proteins from Philippines sea snake venom. * After this manuscript was written, a report by Low et Hermans, unpublished) . From the fitting it appeared either that the sequence of our toxin differs slightly from that of erabutoxin b or that the sequence of erabutoxin b is incorrect in certain places (Fig. 2 ). The differences, however, are smaller than the seven residues reported from earlier chemical studies (3) . The details of the sequence adjustments will be published separately. Having resolved the structure of toxin b, we then investigated the structure of the relatively isomorphous crystals of toxin a by the difference-Fourier technique. A difference Fourier synthesis between two closely related crystal structures is easy to interpret. If the synthesis is calculated with amplitudes (F2-F1), where the Fn are the diffracted amplitudes for structure n, then atoms that are present in structure 2 but not in 1 will appear as peaks in the electron density map, while atoms present in structure 1 but absent in 2 will show up as regions of negative electron density.
Difference electron density maps Data from toxin a were scaled to data from toxin b by making 2Fa2 = 2;Fb2, the sums being over all common reflections. The mean fractional isomorphous difference between the two sets, defined as Z 1 Fa-FbI /Z Fb, was a smooth function of resolution, increasing from 0.128 at 10 A resolution to 0.22 at 2.5 A. This is to be expected from the difference in unit cell dimensions between the two crystals. To determine the difference in electron density between the a and b toxins a Fourier synthesis was calculated with coefficients (Fa-Fb), using phase angles from our earlier determination of the b toxin structure at 2.2 A resolution (1) . That portion of the difference map containing the only significant features is shown in Fig. 3 . The largest feature is a region of negative electron density at the position of His 26, indicating that this amino acid is altered in the a toxin. The only significant positive feature is a spherical peak next to the armino terminus of the protein. In the b toxin structure this position is occupied by a large, dense ball of electron density which we have interpreted as a sulfate ion (Tsernoglou and Petsko, unpublished). Because the a and b toxin crystals were maintained in mother liquor of different pH (8.0 for b, 7.5 for a), we concluded that the peak in the difference map may have been due to a partial loss of bound sulfate ion as the pH was raised.
To test this hypothesis we made use of an earlier set of b data that had been collected at pH 7.5. This data set was scaled to the pH 8 toxin b data by multiplicative adjustment of the F2s; the mean isomorphous difference, E 1 Fb pH 8 -Fb pH 7.51 / p7 pH 8, was 0.I1 and was independent of resolution. This was expected because the crystals were highly isomorphous. A (I) R I C F N Q H S S Q P Q T T K T C P S (1I) R I C F N Q H S S Q P Q T T K T C P S second difference electron density map was calculated with coefficients (Fb pH 7.5 -Fb pH 8), and phases from the 2.2 A study as before. This map had only one feature, a peak at the presumed sulfate position (Fig. 4) (4) . The chemical studies on the Philippines toxins had suggested that they differed sufficiently in composition from the erabutoxins for one to consider the Philippines sea snake a different subspecies (3) . Although the sequences of the Philippines sea snake toxins have not been determined, the 2.2 A electron density map of toxin b indicated that its sequence is extremely similar, and possibly identical, to that of erabutoxin b (1). The present study of Philippines sea snake toxin a reinforces this conclusion. The difference map in Fig. 3 is interpretable by the replacement of His 26 with an asparagine, as in the erabutoxins. In view of this, the earlier suggestion that the two sea snakes may belong to different subspecies requires other evidence. It should be possible to investigate the similarity between our toxin and erabutoxin directly by crystallographic difference-Fourier techniques using our data and those of the group at Columbia working on the erabutoxin structure (2, 11). The two types of toxin have very similar unit cell dimensions, which further suggests that their sequences may be identical. If they are
Comparison of the amino acid sequence of (I) erabutoxin b as determined chemically by Sato and Tamiya (6) Fig. 3 ; the contour levels were chosen in the same way. The absence of features at the His 26 position indicates that their presence in Fig. 3 is not an artifact of the phase determination, because both maps were calculated with the same phase angles. The resolution of the map is 2.5 A.
pointing straight down in Fig. 1 ) that contains nearly all of the amino acids that have been implicated in toxic action. We have previously presented a model for the binding of postsynaptic a-neurotoxins to the acetylcholine receptor in which this loop is inserted into a deep cleft or channel in the membrane-bound receptor (1). The "toxic" residues are indicated in Fig. 1 ; for the most part they are every other residue in the lower part of the extended 3-loop. Thus these "toxic" residues are constrained to point in the same direction (into the plane of the paper in Fig.  1 ), forming an "active surface" which we proposed interacts with a complementary surface on the receptor (1). The His 26
Asn substitution in the sea snake toxins is not harmful to toxic action for two reasons: the side-chain points in the opposite direction from the active surface and so does not interact with the receptor according to our model, and the conformation of the loop is not altered. The difference electron density map shows no change in the position of the backbone or side-chains anywhere else in the neurotoxin molecule.
The binding of the sulfate ion to the amino terminus was useful in confirming our interpretation of the electron-density map, and preliminary studies indicate that the highly isomorphous pair (toxin bpH 8.0, toxin bpH 7.5) may be useful for phase determination. This suggests a possible way of preparing isomorphous derivatives for very small proteins and hormones. (Another approach might be to replace the bound sulfate with a heavier ion such as selenate.) The bound ion also provides information about the state of ionization of the amino terminus.
Finally, the ability of the a-NH3+ to bind ions at physiological pH values raises the question of whether this group participates in the interaction with the receptor. It is not located on or near Biochemistry: Tsernoglou and Petsko I ;-p
